Newsroom | 4553 results

COPENHAGEN, Denmark--(BUSINESS WIRE)--Skape Bio and researchers at the University of Washington’s Institute for Protein Design (IPD) today announced a peer-reviewed study published in the leading international journal Nature demonstrating a new way to design protein-based medicines for G protein-coupled receptors, or GPCRs, one of the most important classes of drug targets in medicine. GPCRs are cell-surface receptors that help the body respond to signals such as hormones, neurotransmitters, an...

EDISON, N.J.--(BUSINESS WIRE)--MTF Biologics, a global nonprofit leader in tissue-based solutions, today announced the appointment of New Horizon Medical Solutions (NHMS) as the exclusive distributor of AmnioBand® Membrane to wound care specialists, podiatrists, and mobile care practitioners across the United States. The agreement combines AmnioBand's peer-reviewed Level 1 clinical evidence base with NHMS's specialized provider network and hands-on field support, creating a distribution model p...

LONDON--(BUSINESS WIRE)--AV Laboratories, a science-led skincare company founded by pioneers in IVF solutions, regenerative medicine, and stem cell therapy, today announced it will exhibit at the 42nd Annual Meeting of the European Society of Human Reproduction and Embryology, ESHRE 2026, taking place in London from 5 - 8 July 2026. The company will welcome clinicians, embryologists, fertility specialists, researchers, partners, and industry participants at Booth A22. “ESHRE is deeply personal...

DURHAM, N.C.--(BUSINESS WIRE)--Precision BioSciences, Inc. (Nasdaq: DTIL), a clinical stage gene editing company utilizing its novel proprietary ARCUS® platform to develop in vivo gene editing therapies for high unmet need diseases, today announced that it will host an investor webcast to discuss new biopsy and clinical data from the ongoing Phase 1 ELIMINATE-B trial. The presentation will include new clinical data along with late-breaker biopsy data featured at the European Association for the...

DALLAS--(BUSINESS WIRE)--Colossal Biosciences, the world's first de-extinction company, today announced that it has successfully hatched multiple healthy chicks from fully artificial eggs. Colossal's incubation platform supports complete avian embryo development outside a biological eggshell, from early embryo to hatch, without the need for supplemental oxygen. The breakthrough is a critical step on the path to de-extincting the South Island Giant Moa and opens new possibilities for avian conse...

LUGANO, Schweiz--(BUSINESS WIRE)--Da das wissenschaftliche Interesse an lichtbasierter Stimulation, neuroendokriner Regulation und integrativer Medizin international weiter zunimmt, hat das Switzerland Eye Research Institute (SERI Lugano) eine neue internationale wissenschaftliche Outreach-Initiative ins Leben gerufen, die sich auf die Einbindung der Öffentlichkeit und die interdisziplinäre Forschungskommunikation in den Bereichen Neurowissenschaften und zelluläre Modulation konzentriert. Die I...

LUGANO, Svizzera--(BUSINESS WIRE)--Mentre aumenta a livello internazionale l'interesse scientifico per la stimolazione basata sulla luce, la regolazione neuroendocrina e la medicina integrativa, lo Switzerland Eye Research Institute (SERI Lugano) ha lanciato una nuova iniziativa scientifica internazionale incentrata sul coinvolgimento del pubblico e sulla comunicazione interdisciplinare nel settore delle neuroscienze e della modulazione cellulare. L'iniziativa mira a promuovere la più ampia com...

LUGANO, Zwitserland--(BUSINESS WIRE)--Nu de wetenschappelijke belangstelling voor lichtstimulatie, neuro-endocriene regulatie en integratieve geneeskunde wereldwijd blijft toenemen, heeft het Switzerland Eye Research Institute (SERI Lugano) een nieuw internationaal wetenschappelijk outreach-initiatief gelanceerd. Dit initiatief richt zich op publieksbetrokkenheid en interdisciplinaire onderzoekscommunicatie op het gebied van neurowetenschappen en celmodulatie. Het initiatief heeft tot doel een...

LUGANO, Suisse--(BUSINESS WIRE)--Alors que l’intérêt scientifique porté à la stimulation par la lumière, à la régulation neuroendocrinienne et à la médecine intégrative ne cesse de croître à l’échelle internationale, le Switzerland Eye Research Institute (SERI, Lugano) vient de lancer une nouvelle initiative scientifique internationale visant à favoriser l’engagement du public et la communication interdisciplinaire dans les domaines des neurosciences et de la modulation cellulaire. L'initiative...

LUGANO, Suiza--(BUSINESS WIRE)--El creciente interés científico por la estimulación basada en la luz, la regulación neuroendocrina y la medicina integrativa ha llevado al Switzerland Eye Research Institute (SERI Lugano) a poner en marcha un nuevo programa internacional de divulgación científica centrado en acercar al público y a la comunidad los avances en neurociencia y modulación celular. El proyecto tiene como objetivo promover una comprensión más amplia de las investigaciones emergentes rel...